venBio Partners LLC Long-Term Concentrated

CIK: 0001776382 · Show all filings

Period: Q4 2020 (← Previous) (Next →)

Filing Date: Feb 16, 2021

Total Value ($000): $1,132,978 (100.0% shares, 0.0% debt)

Holdings (7)

ALXO ALX ONCOLOGY HLDGS INC 73.8%

Value ($000) $836,134 Shares 9,699,925 Est. Cost $39.31 Unrealized +53.0%

HRMY HARMONY BIOSCIENCES HLDGS IN 11.2%

Value ($000) $126,692 Shares 3,504,624 Est. Cost $36.46 Unrealized +10.7%

— AKERO THERAPEUTICS INC 5.6%

Value ($000) $63,063 Shares 2,444,311 Est. Cost $19.15 Unrealized —

— CHECKMATE PHARMACEUTICALS IN 4.7%

Value ($000) $53,595 Shares 3,673,374 Est. Cost $11.51 Unrealized —

APLS APELLIS PHARMACEUTICALS INC 2.5%

Value ($000) $28,055 Shares 490,471 Est. Cost $15.34 Unrealized +175.7%

— METACRINE INC 2.1%

Value ($000) $24,045 Shares 3,059,123 Est. Cost $10.21 Unrealized —

— VERONA PHARMA PLC 0.1%

Value ($000) $1,394 Shares 199,075 Est. Cost $9.65 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ALXO	ALX ONCOLOGY HLDGS INC	9,699,925	$836,134	73.8%	$39.31	+53.0%	COM	00166B105
HRMY	HARMONY BIOSCIENCES HLDGS IN	3,504,624	$126,692	11.2%	$36.46	+10.7%	COM	413197104
—	AKERO THERAPEUTICS INC	2,444,311	$63,063	5.6%	$19.15	—	COM	00973Y108
—	CHECKMATE PHARMACEUTICALS IN	3,673,374	$53,595	4.7%	$11.51	—	COM	162818108
APLS	APELLIS PHARMACEUTICALS INC	490,471	$28,055	2.5%	$15.34	+175.7%	COM	03753U106
—	METACRINE INC	3,059,123	$24,045	2.1%	$10.21	—	COM	59101E103
—	VERONA PHARMA PLC	199,075	$1,394	0.1%	$9.65	—	SPONSORED ADS	925050106